
Rates And Commodities Diverge… Plus Lilly’s Latest Drug Concerns 6/6/24
CNBC's "Fast Money"
00:00
Analysis of a Company's Growth and Eli Lilly's Alzheimer's Treatment Concerns
Discussing a company's expansion efforts with a billion dollar stock buyback and the FDA's scrutiny of an Alzheimer's treatment, weighing the potential market impact.
Play episode from 31:49
Transcript


